Company Overview and News

1
Dropbox Analysts Scour for More Upside as Initiations Loom - Bloomberg

2018-04-16 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
Madalena Announces Attendance at Canaccord’s LATAM One-on-One Day, New York, April 12

2018-04-09 globenewswire
BUENOS AIRES, Argentina, April 09, 2018 (GLOBE NEWSWIRE) -- Madalena Energy Inc. ("Madalena" or the "Company") (TSXV:MVN) (OTCQX: MDLNF) is pleased to announce that the Company will be attending the LATAM One-on-One Day hosted by Canaccord Genuity Group Inc. in New York on Thursday, April 12, 2018.
Upvote Downvote

 
Posting of Annual Report and Notice of Annual General Meeting

2018-04-09 globenewswire
LONDON, April 09, 2018 (GLOBE NEWSWIRE) -- Horizonte Minerals Plc, (AIM:HZM) (TSX:HZM) ('Horizonte' or 'the Company') the nickel development company focused in Brazil, announces that its annual report and accounts for the year ended 31 December 2017, together with Management’s Discussion and Analysis as at 31 December 2017 and Notice of Meeting and Management Information Circular were posted to shareholders on Friday and are available to download on the Company's website at www.
Upvote Downvote

 
Scotiabank, TD have widest U.K. gender pay gaps of Canada banks

2018-04-06 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
Upvote Downvote

 
Alterna CEO embraced weed business when nobody else would

2018-04-06 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
Upvote Downvote

1
Weed Is Serious Business for Canada’s Go-To Pot Banker - Bloomberg

2018-04-03 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
Horizonte Minerals Plc: Final Results

2018-03-27 globenewswire
LONDON, March 27, 2018 (GLOBE NEWSWIRE) -- Horizonte Minerals Plc, (AIM:HZM) (TSX:HZM) (‘Horizonte’ or ‘the Company’) the nickel development company focused in Brazil, announces its final results for the year ended 31 December 2017. Highlights
Upvote Downvote

 
BuildDirect Closes US$43M In Funding Led by Mohr Davidow Ventures; Exits CCAA Protection

2018-03-26 marketwired
VANCOUVER, BC--(Marketwired - March 26, 2018) - BuildDirect, the first technology platform for the home improvement industry, today announced that, in connection with the successful completion of its financial restructuring, it has raised US$28million of new funds and converted US$15 million of Interim Financing provided during the CCAA proceedings for a total raise of US$43 million led by Mohr Davidow Ventures.
Upvote Downvote

 
Future Fibre Technologies Ltd attributed a buy recommendation by Canaccord analyst

2018-03-02 proactiveinvestors.com.au
Future Fibre Technologies Ltd (ASX:FFT) has drawn the attention of Canaccord Genuity Group Inc (TSE:CF) with the broker initiating coverage with a buy recommendation.
Upvote Downvote

2
Canada's Biggest Marijuana Adviser Sees `Robust' Deals, More M&A - Bloomberg

2018-02-07 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
China's Crypto Crackdown Floods Market With Used Mining Rigs - Bloomberg

2018-01-26 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
MOVES-Canaccord Genuity names new head of U.S. cannabis investment banking

2018-01-24 reuters
Jan 24 (Reuters) - Canaccord Genuity, the capital markets division of Canaccord Genuity Group Inc, on Wednesday appointed Shannon Soqui as managing director and head of U.S. cannabis investment banking, expanding its presence in United States.
Upvote Downvote

1
Coinsquare Crypto Exchange Eyes $120 Million IPO in Canada - Bloomberg

2018-01-24 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
Canada's small financial firms get buzz from weed stocks

2018-01-22 cnbc
Investors are betting Canada's smaller financial firms could see a jump in revenues after they helped fund marijuana companies ahead of the country's planned legalization of the drug this year.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: 134801109